Duska LR - Search Results

1

A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.

Duska LR, Petroni GR, Varhegyi N, Brown J, Jelovac D, Moore KN, McGuire WP, Darus C, Barroilhet LM, Secord AA. Duska LR, et al. Gynecol Oncol. 2020 Jun;157(3):585-592. doi: 10.1016/j.ygyno.2019.10.014. Epub 2020 Apr 1. Gynecol Oncol. 2020. PMID: 32247603 Clinical Trial.

2

Fallopian tube carcinoma.

Nikrui N, Duska LR. Nikrui N, et al. Among authors: duska lr. Surg Oncol Clin N Am. 1998 Apr;7(2):363-73. Surg Oncol Clin N Am. 1998. PMID: 9537982 Review.

3

Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer.

Cook S, Penson R, Duska L, Nikrui N, Goodman A, Fuller A, Seiden M. Cook S, et al. Gynecol Oncol. 2000 Apr;77(1):48-54. doi: 10.1006/gyno.1999.5710. Gynecol Oncol. 2000. PMID: 10739690

4

The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma.

Bristow RE, Duska LR, Montz FJ. Bristow RE, et al. Among authors: duska lr. Gynecol Oncol. 2001 Apr;81(1):92-9. doi: 10.1006/gyno.2000.6110. Gynecol Oncol. 2001. PMID: 11277657 Clinical Trial.

5

Paclitaxel and platinum chemotherapy for malignant mixed müllerian tumors of the ovary.

Duska LR, Garrett A, Eltabbakh GH, Oliva E, Penson R, Fuller AF. Duska LR, et al. Gynecol Oncol. 2002 Jun;85(3):459-63. doi: 10.1006/gyno.2002.6645. Gynecol Oncol. 2002. PMID: 12051874

6

Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors.

Campos SM, Matulonis UA, Penson RT, Lee H, Berkowitz RS, Duska LR, Fuller AF Jr, Wilson KS, Puchalski TA, Supko JG, Seiden MV. Campos SM, et al. Among authors: duska lr. Gynecol Oncol. 2003 Sep;90(3):610-8. doi: 10.1016/s0090-8258(03)00373-1. Gynecol Oncol. 2003. PMID: 13678734 Clinical Trial.

7

A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies.

Matulonis U, Campos S, Duska L, Fuller A, Berkowitz R, Gore S, Roche M, Colella T, Lee H, Seiden MV; Gynecologic Oncology Research Program at Dana Farber/Partners Cancer Care; Dana Farber-Harvard Cancer Care. Matulonis U, et al. Gynecol Oncol. 2003 Nov;91(2):293-8. doi: 10.1016/s0090-8258(03)00496-7. Gynecol Oncol. 2003. PMID: 14599858 Clinical Trial.

8

Phase II trial of anastrozole in women with asymptomatic müllerian cancer.

del Carmen MG, Fuller AF, Matulonis U, Horick NK, Goodman A, Duska LR, Penson R, Campos S, Roche M, Seiden MV. del Carmen MG, et al. Among authors: duska lr. Gynecol Oncol. 2003 Dec;91(3):596-602. doi: 10.1016/j.ygyno.2003.08.021. Gynecol Oncol. 2003. PMID: 14675683 Clinical Trial.

9

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.

Duska LR, Berkowitz R, Matulonis U, Muto M, Goodman A, McIntyre JF, Klein A, Atkinson T, Seiden MV, Campos S. Duska LR, et al. Gynecol Oncol. 2005 Jan;96(1):198-203. doi: 10.1016/j.ygyno.2004.09.022. Gynecol Oncol. 2005. PMID: 15589601 Clinical Trial.

10

Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer.

Matulonis UA, Campos S, Duska L, Krasner CN, Atkinson T, Penson RT, Seiden MV, Verrill C, Fuller AF, Goodman A; Gynecologic Cancer Program of Dana Farber-Harvard Cancer Center. Matulonis UA, et al. Gynecol Oncol. 2006 Oct;103(1):160-4. doi: 10.1016/j.ygyno.2006.02.017. Epub 2006 Mar 29. Gynecol Oncol. 2006. PMID: 16566993 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page